- Home
- AKRO vs FBP Comparison
AKRO vs FBP Comparison
Compare AKRO & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- FBP
- Stock Information
- Founded
- AKRO 2017
- FBP 1948
- Country
- AKRO United States
- FBP United States
- Employees
- AKRO N/A
- FBP N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- FBP Major Banks
- Sector
- AKRO Health Care
- FBP Finance
- Exchange
- AKRO Nasdaq
- FBP Nasdaq
- Market Cap
- AKRO 3.9B
- FBP 3.4B
- IPO Year
- AKRO 2019
- FBP N/A
- Fundamental
- Price
- AKRO $49.65
- FBP $19.96
- Analyst Decision
- AKRO Strong Buy
- FBP Buy
- Analyst Count
- AKRO 8
- FBP 4
- Target Price
- AKRO $82.50
- FBP $22.50
- AVG Volume (30 Days)
- AKRO 1.9M
- FBP 1.1M
- Earning Date
- AKRO 05-12-2025
- FBP 07-22-2025
- Dividend Yield
- AKRO N/A
- FBP 3.60%
- EPS Growth
- AKRO N/A
- FBP 4.49
- EPS
- AKRO N/A
- FBP 1.84
- Revenue
- AKRO N/A
- FBP $884,832,000.00
- Revenue This Year
- AKRO N/A
- FBP $2.26
- Revenue Next Year
- AKRO N/A
- FBP $6.94
- P/E Ratio
- AKRO N/A
- FBP $10.86
- Revenue Growth
- AKRO N/A
- FBP 2.45
- 52 Week Low
- AKRO $17.86
- FBP $16.40
- 52 Week High
- AKRO $58.40
- FBP $22.40
- Technical
- Relative Strength Index (RSI)
- AKRO 63.34
- FBP 48.21
- Support Level
- AKRO $44.94
- FBP $19.73
- Resistance Level
- AKRO $49.29
- FBP $20.63
- Average True Range (ATR)
- AKRO 3.33
- FBP 0.33
- MACD
- AKRO 0.67
- FBP -0.14
- Stochastic Oscillator
- AKRO 86.02
- FBP 15.52
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.